Track topics on Twitter Track topics that are important to you
Roche is aiming to shore up its place in the haemophilia drug market, with Hemlibra (emicizumab) on the brink of regulatory approval for expanded use. The US Food and Drug Administration (FDA) is this week expected to grant the Swiss pharma giant ...
Original Article: Roche poised for push into haemophilia marketNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...